Xeris Biopharma Holdings, Inc. 4

CFO Steven Pieper sold 5,000 shares of Xeris Biopharma Holdings, Inc. common stock at $8.50 per share under a Rule 10b5-1 plan.

On 2026-09-01, Xeris Biopharma Holdings, Inc. Chief Financial Officer Steven Pieper sold 5,000 shares of the company’s common stock at an average price of $8.50 per share, for total proceeds of approximately $42,500. Following this Rule 10b5-1 plan trade, his direct holdings stand at 1,356,053 shares of common stock, representing a substantial continuing equity interest in the company.

Filing Facts

CIK

1867096

Ticker

XERS

Form

4

Source Type

fda

Accession

0001875714-26-000012

Alert Tier

5